Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

M B Tyers

Showing results (81-90 of 90) with videos related to

Pageof 9
Sort By:
You have reached the last page of results.This site can display upto 90 results.
Nature|August 11, 1972
Short-lasting, competitive neuromuscular blocking activity in a series of azobis-arylimidazo-(1,2-a)-pyridinium dihalidesL Bolger, R T Brittain, D Jack, et al.
British Journal of Pharmacology|April 1, 1988
The potential anxiolytic activity of GR38032F, a 5-HT3-receptor antagonistB J Jones, B Costall, A M Domeney, et al.
Pharmacology, Biochemistry, and Behavior|December 1, 1989
The effects of ondansetron (GR38032F) in rats and mice treated subchronically with diazepamB Costall, B J Jones, M E Kelly, et al.
Cancer Treatment Reviews|December 1, 1987
Antiemetic properties of the 5HT3-receptor antagonist, GR38032FR Stables, P L Andrews, H E Bailey, et al.
British Journal of Pharmacology|July 1, 1991
Neuroprotective actions of GR89696, a highly potent and selective kappa-opioid receptor agonistP J Birch, H Rogers, A G Hayes, et al.
British Journal of Anaesthesia|June 1, 1973
Placental transfer of AH8165C E Blogg, B R Simpson, M B Tyers, et al.
British Journal of Pharmacology|December 1, 1990
A series of novel, highly potent and selective agonists for the kappa-opioid receptorA G Hayes, P J Birch, N J Hayward, et al.
European Journal of Pharmacology|January 16, 1995
GR159897, a potent non-peptide antagonist at tachykinin NK2 receptorsI J Beresford, R L Sheldrick, D I Ball, et al.
Pharmacology, Biochemistry, and Behavior|April 1, 1990
The effects of ondansetron, a 5-HT3 receptor antagonist, on cognition in rodents and primatesJ M Barnes, B Costall, J Coughlan, et al.
Brain : a Journal of Neurology|February 1, 1986
Neuropeptides and dopamine in the marmoset. Effect of treatment with 1-methyl-4-phenyl-1, 2, 3, 6 tetrahydropyridine (MPTP): an animal model for Parkinson's disease?J M Allen, A J Cross, J C Yeats, et al.
Pageof 9

Showing results (81-90 of 90) with videos related to

Sort By:
Pageof 9
You have reached the last page of results.This site can display upto 90 results.
Nature|August 11, 1972
Short-lasting, competitive neuromuscular blocking activity in a series of azobis-arylimidazo-(1,2-a)-pyridinium dihalidesL Bolger, R T Brittain, D Jack, et al.
British Journal of Pharmacology|April 1, 1988
The potential anxiolytic activity of GR38032F, a 5-HT3-receptor antagonistB J Jones, B Costall, A M Domeney, et al.
Pharmacology, Biochemistry, and Behavior|December 1, 1989
The effects of ondansetron (GR38032F) in rats and mice treated subchronically with diazepamB Costall, B J Jones, M E Kelly, et al.
Cancer Treatment Reviews|December 1, 1987
Antiemetic properties of the 5HT3-receptor antagonist, GR38032FR Stables, P L Andrews, H E Bailey, et al.
British Journal of Pharmacology|July 1, 1991
Neuroprotective actions of GR89696, a highly potent and selective kappa-opioid receptor agonistP J Birch, H Rogers, A G Hayes, et al.
British Journal of Anaesthesia|June 1, 1973
Placental transfer of AH8165C E Blogg, B R Simpson, M B Tyers, et al.
British Journal of Pharmacology|December 1, 1990
A series of novel, highly potent and selective agonists for the kappa-opioid receptorA G Hayes, P J Birch, N J Hayward, et al.
European Journal of Pharmacology|January 16, 1995
GR159897, a potent non-peptide antagonist at tachykinin NK2 receptorsI J Beresford, R L Sheldrick, D I Ball, et al.
Pharmacology, Biochemistry, and Behavior|April 1, 1990
The effects of ondansetron, a 5-HT3 receptor antagonist, on cognition in rodents and primatesJ M Barnes, B Costall, J Coughlan, et al.
Brain : a Journal of Neurology|February 1, 1986
Neuropeptides and dopamine in the marmoset. Effect of treatment with 1-methyl-4-phenyl-1, 2, 3, 6 tetrahydropyridine (MPTP): an animal model for Parkinson's disease?J M Allen, A J Cross, J C Yeats, et al.
Pageof 9